Loading...
The Role of Anti-angiogenesis in Non-small-cell Lung Cancer: an Update
Recognition of the vascular endothelial growth factor (VEGF) pathway as a key mediator of angiogenesis has led to the clinical study of several VEGF and VEGF receptor (VEGFR) targeted therapies in non-small-cell lung cancer (NSCLC). These targeted therapies include neutralizing antibodies to VEGF (b...
Na minha lista:
| Udgivet i: | Curr Oncol Rep |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4836185/ https://ncbi.nlm.nih.gov/pubmed/25947099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-015-0448-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|